MyAverix Finance
TW · Healthcare
A Plus Biotechnology Co., Ltd. (6918)
Medical Devices
A Plus Biotechnology Co., Ltd. (6918) is listed on TW in the Healthcare sector. Industry: Medical Devices. As of 2026-03-29, reported market cap is $2.74B, P/E ratio is 15.61, net margin is 20.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6918
A Plus Biotechnology Co., Ltd. (6918) — FAQ
What is A Plus Biotechnology Co., Ltd.'s market cap?
A Plus Biotechnology Co., Ltd. (6918) has a reported market cap of $2.74B (data as of 2026-03-29).
What is 6918's P/E ratio?
The price-to-earnings (P/E) ratio for A Plus Biotechnology Co., Ltd. (6918) is 15.61 (data as of 2026-03-29).
Does A Plus Biotechnology Co., Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for A Plus Biotechnology Co., Ltd. (6918). Check the MyAverix Finance app for the latest dividend data.
What sector is A Plus Biotechnology Co., Ltd. in?
A Plus Biotechnology Co., Ltd. (6918) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 6918 listed on?
6918 is listed on TW.
What is A Plus Biotechnology Co., Ltd.'s net margin?
A Plus Biotechnology Co., Ltd. (6918) reports a net margin of 20.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.